RevMedica becomes the only Endo Stapling Platform accepted into FDA’s STeP. The Company also expands its intellectual property protection with 5 new patents. MIDDLETOWN, Conn., Jan. 22, 2025 /PRNewswire/ — RevMedica™, Inc. is pleased to announce its’ Endo Stapling Platform has been…